Physician and pharmacologist
Louis S. Goodman
Yale School of Medicine
Described by Christakis (2011) as a physician and pharmacologist who, with the pharmacologist Alfred Gilman, led a Yale research team funded by the US Office of Scientific Research and Development during the Second World War; the team's work on nitrogen mustard led to its first use in a patient with lymphosarcoma. First author listed in PubMed for the 1946 JAMA report on nitrogen mustard therapy for Hodgkin disease, lymphosarcoma, leukemia and allied disorders.
Milestones
Sources
Christakis P. The birth of chemotherapy at Yale. Bicentennial lecture series: Surgery Grand Round. Yale J Biol Med. 2011;84(2):169-72.
Goodman LS, Wintrobe MM, et al. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J Am Med Assoc. 1946;132:126-32.